EEG Biomarkers
Cross-source consensus on EEG Biomarkers from 1 sources and 3 claims.
1 sources · 3 claims
Risks & contraindications
Evidence quality
Where it comes from
Highlighted claims
- EEG biomarker discovery for Parkinson's disease is vulnerable to site-specific artifacts and acquisition context. — Robust and Clinically Reliable EEG Biomarkers: A Cross Population Framework for Generalizable Parkinson's Disease Detection
- EEG cohorts vary in hardware, recording protocols, medication state, and preprocessing-relevant acquisition details. — Robust and Clinically Reliable EEG Biomarkers: A Cross Population Framework for Generalizable Parkinson's Disease Detection
- Robust EEG biomarker discovery should emphasize directionality and stability rather than pooled or within-site accuracy alone. — Robust and Clinically Reliable EEG Biomarkers: A Cross Population Framework for Generalizable Parkinson's Disease Detection